- Home
- Our areas of action
- Meeting major societal challenges
- Women’s health
Fighting injustice
accelerate research into women's health

Health inequalities between women and men persist. Fewer than 3 out of 10 women feel fully informed about prevention, screening and frequency of follow-up, and only 2 out of 10 about health trends over the course of a lifetime. Three quarters of women feel that it is still difficult to reconcile motherhood and professional life.
It’s in the workplace that the condition of women is particularly worrying. Over 10% of female employees suffer from a work-related illness, and almost 60% report pain linked to musculoskeletal disorders. What’s more, a worrying 17% of women have experienced a depressive episode in the last 12 months.

Women are under-represented in health studies and clinical trials, and their pain is often trivialized.
30%
of women are more likely than men to present with stroke symptoms, then to be misdiagnosed before being sent home.
Testimonial
“Women’s health is now better taken into account, particularly in the areas of fertility, osteoporosis, endometriosis, contraception and menopause. But there are still many unexplored fields and gaps in care, such as cardiovascular disease and pain management. We therefore need to launch new research projects, which the Inserm Foundation will be able to support.
Marina Kvaskoff – epidemiologist and Inserm researcher in the “Exposome, Heredity, Cancer and Health” team at the Centre de recherche en épidémiologie et santé des populations in Villejuif.
Marina Kvaskoff is dedicated to the study of endometriosis, a disease that affects 10% of women in France. Currently, it takes between 6 and 10 years for a diagnosis to be made, once symptoms have appeared, which considerably delays treatment. Marina Kvaskoff’s research also focuses on fibroids, a pathology which affects 25% of women in France, and about which little is known.
This work can be supported by the Inserm Foundation, with your help, so that these diseases are better understood and taken into account in research and access to care. They have a major impact on women’s quality of life, and on the economy of companies, because of the absences and difficulties they can cause.